Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?

: Evidence shows that COPD-OSA overlap syndrome (OS) is more frequently accompanied by cardiovascular disease (CVD) in comparison to either disease alone. The aim of the study was to explore whether patients with OS have a higher burden of subclinical myocardial injury and wall stress compared with OSA patients. : Consecutive patients, without established CVD, underwent polysomnography and pulmonary function testing, due to suspected sleep-disordered breathing. An equal number of patients with OS ( = 53, with an apnea hypopnea index (AHI) > 5/h and FEV/FVC < 0.7) and patients with OSA ( = 53, AHI > 5/h and FEV/FVC > 0.7) were included in the study. The detection of asymptomatic myocardial injury and wall stress was performed via the assessment of serum high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), respectively. : OS patients were older ( < 0.001) and had worse hypoxemic parameters, namely average oxyhemoglobin saturation (SpO2) ( = 0.002) and time spent with SpO2 < 90% ( = 0.003) during sleep as well as daytime pO2 ( < 0.001), than patients with OSA. No difference was observed between groups in terms of Epworth Sleepiness Scale ( = 0.432) and AHI ( = 0.587). Both levels of hs-cTnT (14.2 (9.1-20.2) vs. 6.5 (5.6-8.7) pg/mL, < 0.001) and NT-proBNP (93.1 (37.9-182.5) vs. 19.2 (8.3-35.4) pg/mL, < 0.001) were increased in OS compared to OSA patients. Upon multivariate linear regression analysis, levels of NT-proBNP and hs-cTnT correlated with age and average SpO2 during sleep. : Our study demonstrated higher levels of hs-cTnT and NT-proBNP in OS patients, indicating an increased probability of subclinical myocardial injury and wall stress, compared with OSA individuals.